VIVA Biotech Holdings
HKEX:1873
VIVA Biotech Holdings
Revenue
VIVA Biotech Holdings
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
V
|
VIVA Biotech Holdings
HKEX:1873
|
Revenue
¥2.2B
|
CAGR 3-Years
46%
|
CAGR 5-Years
59%
|
CAGR 10-Years
N/A
|
WuXi AppTec Co Ltd
SSE:603259
|
Revenue
¥40.3B
|
CAGR 3-Years
35%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Revenue
¥11.5B
|
CAGR 3-Years
31%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Revenue
¥17B
|
CAGR 3-Years
45%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Revenue
¥7.4B
|
CAGR 3-Years
32%
|
CAGR 5-Years
26%
|
CAGR 10-Years
36%
|
|
M
|
MGI Tech Co Ltd
SSE:688114
|
Revenue
¥4.2B
|
CAGR 3-Years
57%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is VIVA Biotech Holdings's Revenue?
Revenue
2.2B
CNY
Based on the financial report for Dec 31, 2023, VIVA Biotech Holdings's Revenue amounts to 2.2B CNY.
What is VIVA Biotech Holdings's Revenue growth rate?
Revenue CAGR 5Y
59%
Over the last year, the Revenue growth was -9%. The average annual Revenue growth rates for VIVA Biotech Holdings have been 46% over the past three years , 59% over the past five years .